文献速递免疫规划传染病防控与疫情报告

表达多价交叉保护拉沙病毒糖蛋白的甲病毒载体复制子颗粒

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
PubMed 文献 · Vaccine · 2017-12-26

拉沙病毒(LASV)在西非流行且遗传多样性高,是疫苗研发难点。研究者以委内瑞拉马脑炎TC-83 IND疫苗(VEEV)为基础,构建表达远缘分支I和IV LASV糖蛋白(GPC)的双顺反子RNA复制子颗粒(VLPVs),在小鼠中具免疫原性和保护性,并诱导针对分支I-IV的交叉反应多功能T细胞应答。

要点

  • VLPVs将LASV分支I和IV的GPC与改造型ΔGPfib共表达于甲病毒26S启动子下。
  • ΔGPfib主要以三聚体形式在内质网蓄积,诱导内质网应激和凋亡以促进抗原交叉致敏。
  • VLPV疫苗在小鼠中具免疫原性和保护性,并诱导针对LASV分支I-IV的交叉反应多功能T细胞应答。

核心结论

  • 多价RNA复制子为基础的LASV疫苗可适用于一线响应人员、访问流行区的国际旅行者、军人和实验室人员。

研究设计与样本

  • 以人委内瑞拉马脑炎TC-83 IND疫苗(VEEV)为基础,构建双顺反子RNA复制子颗粒(VLPVs),将VEEV结构蛋白基因替换为分别由26S启动子驱动的远缘分支I和IV LASV糖蛋白(GPC)基因。
  • 将编码野生型LASV GPC(GPCwt)和C端缺失、不可切割的改造糖蛋白(ΔGPfib)的双顺反子RNA复制子,利用反式提供的VEEV衣壳和糖蛋白包装成VLPV颗粒。
  • 在转导细胞中,VLPVs同时表达LASV GPCwt和ΔGPfib;在小鼠中评价免疫原性和保护性。

主要发现

  • LASV ΔGPfib主要以三聚体形式表达,蓄积于内质网,诱导内质网应激和凋亡,促进抗原交叉致敏。
  • VLPV疫苗在小鼠中具免疫原性和保护性,并上调CD11c+/CD8+树突状细胞,其在交叉呈递中起主要作用。
  • VLPV免疫后,用源自LASV分支I-IV的肽混合物刺激免疫脾细胞,可诱导交叉反应多功能T细胞应答。

临床怎么用

  • 原文结论指出,多价RNA复制子为基础的LASV疫苗可适用于一线响应人员、访问流行区的国际旅行者、军人和实验室人员。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lassa virus (LASV) is the most prevalent rodent-borne arenavirus circulated in West Africa. With population at risk from Senegal to Nigeria, LASV causes Lassa fever and is responsible for thousands of deaths annually. High genetic diversity of LASV is one of the challenges for vaccine R&D. We developed multivalent virus-like particle vectors (VLPVs) derived from the human Venezuelan equine encephalitis TC-83 IND vaccine (VEEV) as the next generation of alphavirus-based bicistronic RNA replicon particles. The genes encoding VEEV structural proteins were replaced with LASV glycoproteins (GPC) from distantly related clades I and IV with individual 26S promoters. Bicistronic RNA replicons encoding wild-type LASV GPC (GPCwt) and C-terminally deleted, non-cleavable modified glycoprotein (ΔGPfib), were encapsidated into VLPV particles using VEEV capsid and glycoproteins provided in trans. In transduced cells, VLPVs induced simultaneous expression of LASV GPCwt and ΔGPfib from 26S alphavirus promoters. LASV ΔGPfib was predominantly expressed as trimers, accumulated in the endoplasmic reticulum, induced ER stress and apoptosis promoting antigen cross-priming. VLPV vaccines were immunogenic and protective in mice and upregulated CD11c+/CD8+ dendritic cells playing the major role in cross-presentation. Notably, VLPV vaccination resulted in induction of cross-reactive multifunctional T cell responses after stimulation of immune splenocytes with peptide cocktails derived from LASV from clades I-IV. Multivalent RNA replicon-based LASV vaccines can be applicable for first responders, international travelers visiting endemic areas, military and lab personnel.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang M, Jokinen J, Tretyakova I, et al. Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins. Vaccine. 2017. PMID: 29287681. doi:10.1016/j.vaccine.2017.12.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。